Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biotechnology Index NYSE ETF (NY: FBT )

162.43 USD -0.03 (-0.02%)
Official Closing Price Updated: 7:59 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biotechnology Index NYSE ETF

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
Taking the Technical Temperature of Biotech ETFs
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds have been hampered by presidential politics this year.... 
Tags XBI BIS Biotechnology
From ETF Trends
Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech
Drug pricing has been one of the hot topics of the year. As Citron Research's controversial executive editor Andrew Left said last ... 
Tags Benzinga Health Care Andrew Left
From Benzinga
Investors Grab NKTR Even Cheaper Than Its Secondary Stock Offering
Looking back to 2 days ago, Nektar Therapeutics (NKTR) priced a 13,000,000 share secondary stock offering at $13.50 per share. Buyers in that offering made a considerable investment into the company,... 
Tags Stocks
From Market News Video
Acadia Pharmaceuticals Enters Oversold Territory (ACAD)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
The Way to Profit From the Biotech Story No One Is Talking About
By the standard of today’s mega-mergers, a $4 million investment seems like pretty small change. 
Tags ETF's Healthcare Stocks / Equities
From Blogs - TalkMarkets
Analysts Anticipate FBT Will Reach $119
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Candidate Clinton's Proposal To Combat Drug Price Hikes
Hillary Clinton, Democratic presidential nominee, introduced a new plan to address the "unjustified" price increases on life-savings ... 
Tags SPY Reuters Health Care
From Benzinga
Top Buys by Directors: Bonney's $116.7K Bet on ALNY
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... 
Tags Stocks
From Market News Video
Grifols Barcelona Enters Oversold Territory (GRFS)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
RSI Alert: Bio-Techne (TECH) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Top Buys by Top Brass: President & C.E.O. Capone's $212.4K Bet on MYGN
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider... 
Tags Stocks
From Market News Video
Snag This Bargain Even Cheaper Than President Myriad RBM, Inc. McDade Did
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 12, Myriad Genetics, Inc.'s President Myriad RBM,... 
Tags Stocks
From Market News Video
Another Endorsement for Biotech ETFs
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds, seem to have put the woes experienced earlier this year... 
Tags Equities FBT REGN
From ETF Trends
Large Cap Biopharmaceutical Metrics: Valuation Models For Future Growth
We reviewed large cap biotech stocks on July 3 just after the BREXIT bottom but prior to Q2 earnings and on May 8 after Q1 earnings. Here is data that offer comparisons of the core large cap holdings... 
Tags Healthcare ETF's Stocks / Equities
From Blogs - TalkMarkets
Investors Land ACAD 6.0% Cheaper Than Its Secondary Stock Offering
Looking back to 2 days ago, Acadia Pharmaceuticals Inc (ACAD) priced a 6,060,606 share secondary stock offering at $33.00 per share. Buyers in that offering made a considerable investment into the... 
Tags Stocks
From Market News Video
Wednesday's ETF Movers: GDX, FBT
In trading on Wednesday, the Gold Miners ETF (GDX) is outperforming other ETFs, up about 2% on the day. Components of that ETF showing particular strength include shares of Tahoe Resources (TAHO), up... 
Tags ETFs
From ETF Channel
Surprising Analyst 12-Month Target For FBT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Alkermes (ALKS) Shares Cross Above 200 DMA
In trading on Monday, shares of Alkermes plc (ALKS) crossed above their 200 day moving average of $50.15, changing hands as high as $50.31 per share. Alkermes plc shares are currently trading up about... 
Tags Stocks
From Market News Video
Bullish Two Hundred Day Moving Average Cross - FBT
In trading on Thursday, shares of the First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) crossed above their 200 day moving average of $95.72, changing hands as high as $96.60 per share. First... 
Tags ETFs
From ETF Channel
Analysts Forecast 27% Upside For FBT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biotech ETFs: Will the Once Hot Group Rebound?
The struggling biotechnology group and exchange traded funds such as the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, are leaving investors wondering... 
Tags equities XBI IBB
From ETF Trends
Large Cap Biopharmaceuticals-Valuation Models 2016
The biotech sector has underperformed the market because of the severe correction in August/September of 2015 followed by another downdraft in January 2016 all the result of “bubble” valuations. 
Tags Healthcare ETF's Pharma/Biotech
From Blogs - TalkMarkets
JUNO Crosses Below Key Moving Average Level
In trading on Tuesday, shares of Juno Therapeutics Inc (JUNO) crossed below their 200 day moving average of $41.95, changing hands as low as $41.82 per share. Juno Therapeutics Inc shares are currently... 
Tags Stocks
From Market News Video
Expect More Election Year Volatility For Biotech ETFs
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have disappointed investors for close to a year. Unfortunately, election... 
Tags featured FBT XBI
From ETF Trends
Neurocrine Biosciences Breaks Below 200-Day Moving Average - Notable for NBIX
In trading on Tuesday, shares of Neurocrine Biosciences, Inc. (NBIX) crossed below their 200 day moving average of $45.94, changing hands as low as $45.72 per share.. 
Tags Stocks
From Market News Video
FBT's Underlying Holdings Could Mean 28% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Oversold Conditions For Myriad Genetics (MYGN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
A Catalyst for Biotech ETFs
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, is up 9.2% over the past month. Performances for some rival biotech ETFs have been even better and... 
Tags IBB XBI equities
From ETF Trends
Trying to Believe in Biotech ETFs
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs are vexing investors this year. Just when turnarounds for these funds look... 
Tags IBB XBI equities
From ETF Trends
AGIO Crosses Above Key Moving Average Level
In trading on Thursday, shares of Agios Pharmaceuticals Inc (AGIO) crossed above their 200 day moving average of $58.79, changing hands as high as $60.20 per share. Agios Pharmaceuticals Inc shares are... 
Tags Stocks
From Market News Video
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.